LCN2 and infection: So far, MSCs have been found to constitutively express four AMPs: cathelicidin LL-37 (19, 23), human β-defensin-2 (hBD-2) (24), hepcidin (20), and lipocalin-2 (Lcn2) (26), which can be further modulated during infection and inflammation.